Form D Summary: Cultivation Capital Life Sciences Fund II Filing. William Schmidt Published Nov 1 D Filing

Pooled Investment Fund Cultivation Capital Life Sciences Fund II, Llc - William Schmidt

Cultivation Capital Life Sciences Fund II Form D

The Missouri-based Cultivation Capital Life Sciences Fund II, Llc submitted Form D about $40.00 million offering. This is a new filing. The Limited Liability Company raised $2.25 million so far. That is 5.63% of the $40.00 million private offering. The total offering amount was $40.00 million. The offering filing was filed on 2016-11-01. Cultivation Capital Life Sciences Fund II, Llc’s clarification was: The Issuer?s manager is entitled to carried interest and the investment manager is entitled to a management fee. The carried interest and management fee are fully disclosed in the Issuer’s confidential offering materials.. The offering has $37.75 million left to be raised and is still open.

Cultivation Capital Life Sciences Fund II is based in Missouri. The firm’s business is Pooled Investment Fund. The D form was signed by William Schmidt Manager of Cultivation Capital Life Sciences Fund II Manager. The company was incorporated in 2016. The filler’s address is: 911 Washington Avenue, Suite 801, St. Louis, Mo, Missouri, 63101. – – Cultivation Capital Life Sciences Fund Ii Manager, Llc is the related person in the form and it has address: 911 Washington Avenue, Suite 801, St. Louis, Mo, Missouri, 63101. Link to Cultivation Capital Life Sciences Fund II Filing: 000168800516000002.

Analysis of Cultivation Capital Life Sciences Fund II Offering

On average, companies in the Pooled Investment Fund sector, sell 37.80% pooled investment interest. Cultivation Capital Life Sciences Fund II sold 5.63% of the offering. The average investment offering size is $24.76 million for companies in the Pooled Investment Fund industry sector. The total amount raised is 90.91% smaller than the average for companies in the Pooled Investment Fund sector.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Related posts

Leave a Comment